Zobrazeno 1 - 10
of 96
pro vyhledávání: '"G H, Blijham"'
Autor:
M.G. Demedts, Johan Vansteenkiste, J. B. E. Smeets, G. H. Blijham, Frans L. G. Erdkamp, Martin J. Muller, Emiel F.M. Wouters, E. J. Schoon, G. P. M. Ten Velde, H. F. P. Hillen, B. M. Drenth, Neil K. Aaronson, Harry C. Schouten, Jean Simons, E. G. M. Cobben
Publikováno v:
Journal of Clinical Oncology, 14, 1077-1084. American Society of Clinical Oncology
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.Simons JP, Aaronson NK, Vansteenkiste JF, ten Velde GP, Muller MJ, Drenth BM, Erdka
Autor:
Jan Willem Arends, F. J. G. M. Kubben, G. H. Blijham, Reinhold W. Stockbrügger, Cor G. M. I. Baeten, Leopold G.J.B. Engels, A. Peeters-Haesevoets, Bert Schutte
Publikováno v:
Gut, 35(4), 530-535. BMJ Publishing Group
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation.Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, Stockbrugger RW, Blijham GH.Division of Haemato-Oncology, Academic Hospital
Autor:
G. P. M. Ten Velde, F. C. S. Ramaekers, M. M. F. J. Tinnemans, G. H. Blijham, Bert Schutte, M.-H. Lenders
Publikováno v:
British Journal of Cancer
Cytokinetic parameters of various types of lung cancer were determined in bronchoscopy specimens after in vivo labelling with the thymidine analogue bromodeoxyuridine (BrdU). The S-phase fraction and BrdU labelling index were measured flow cytometric
Autor:
A. C. M. Winters van der Meer, M. A. P. Mens, Rudolf B Kool, G. H. Blijham, C. M. A. Veldkamp, J.C.J.M. de Haes, S. M. Kleefstra
Publikováno v:
Quality & safety in health care, 19(5). BMJ Publishing Group
Quality & Safety in Health Care, 19(5). BMJ Publishing Group
Quality & Safety in Health Care, 19(5). BMJ Publishing Group
Background Patient satisfaction is one of the relevant indicators of quality of care; however, measuring patient satisfaction had been criticised. A major criticism is that many instruments are not reliable and/or valid. The instruments should have e
Autor:
M. Reynders, Jürgen Spona, Angelika Reiner, G. Reiner, C. van Asche, Günther G. Steger, Bert Schutte, Michael Schemper, Raimund Jakesz, G. H. Blijham, M. Grant
Publikováno v:
European Surgery. 23:43-48
Tumoren von 191 Mammakarzinompatientinnen einer randomisierten Studie werden mit Hilfe der DNA-Flowzytometrie evaluiert. DNA-Index (DNI) und der Anteil der Zellen in der Synthesephase (SPF) werden auf ihre Korrelationen mit prognostischen Faktoren hi
Publikováno v:
European Journal of Cancer. 33:815-817
Autor:
J, Wils, G H, Blijham, Th, Wagener, J, De Greve, R L H, Jansen, T C, Kok, J W R, Nortier, H, Bleiberg, M L, Couvreur, B, Genicot, B, Baron
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(3)
The aim of this study was to investigate whether N-(phosphonacetyl)-L-aspartic acid (PALA) can enhance the activity of low-dose methotrexate (LD-MTX) modulated infusional 5-fluorouracil (5-FU) in patients with advanced colorectal cancer. 198 patients
Autor:
G H, Blijham
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 146(15)
According to Poolman et al. (this issue), 6% of patients visiting the casualty department of a large Amsterdam hospital and requiring hospital admission had to be transported elsewhere at the expense of a considerable administrative effort on the par
Publikováno v:
Headneck. 22(8)
Head and neck cancer and its treatment can have important psychosocial implications, and many patients become depressed. The aim of this prospective study is to examine whether pretreatment variables can be used to predict depression 6 and 12 months
Publikováno v:
Headneck. 22(4)
Quality of life (QOL) has become an important issue in head and neck cancer. Explanation of factors predicting QOL after treatment has important implications for patient management.In this prospective study we analyzed which pretreatment factors pred